Dr Prue Gregory, and Dr Aron Chakera
Semaglutide approved for diabetic chronic kidney disease
Semaglutide has been approved as an adjunct to care for declining kidney function and to reduce cardiovascular death in adults with type 2 diabetes.
About the Authors
Subscribe to continue reading
Log in or create an account to access the full article.